An Open-Label, Study to Treat Patients With Renal Allograft and Polyoma BK Viruria

Summary

This study will evaluate the clinical efficacy and safety of a combination of leflunomide and orotic acid in kidney transplant patients with high levels of Polyoma BK viruria for the purpose of preventing Polyoma BK viremia and Nephropathy that could lead to kidney transplant loss from viral damage, acute rejection or both.

Timeline

Start

2012-07

Primary completion

2018-06

Completion

2018-06

Outcome

Outcome not reported

Stopped (Enrollment): “Lack of recruitment”

Drugs

Indications

No indication recorded.